Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease

Published:2015-08-07 Issue:8 Volume:10 Page:e0134172
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yan Hong-Mei,Xia Ming-Feng,Wang Yan,Chang Xin-Xia,Yao Xiu-Zhong,Rao Sheng-Xiang,Zeng Meng-Su,Tu Yin-Fang,Feng Ru,Jia Wei-Ping,Liu Jun,Deng Wei,Jiang Jian-Dong,Gao Xin

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Non-alcoholic fatty liver disease: the mist gradually clears;NM de Alwis;J Hepatol,2008

2. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;GC Farrell;Hepatology,2006

3. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;QM Anstee;Nat Rev Gastroenterol Hepatol,2013

4. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study;LA Adams;Am J Gastroenterol,2009

5. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis;R Belfort;N Engl J Med,2006

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD;Journal of Ethnopharmacology;2024-10

3. Nutraceutical and dietary measures with potential for preventing/controlling non-alcoholic fatty liver disease and its complications;Human Nutrition & Metabolism;2024-09

4. Berberine attenuates TNBS-induced colitis in mice by improving the intestinal microbiota;Frontiers in Microbiology;2024-08-29

5. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15